Comments
Loading...

Abivax

ABVXNASDAQ
Logo brought to you by Benzinga Data
$6.15
-0.35-5.38%
At close: -
$6.43
0.284.55%
After Hours: 8:53 AM EDT
Consensus Rating1
Buy
Highest Price Target1
$50.00
Lowest Price Target1
$16.00
Consensus Price Target1
$35.63

Abivax (NASDAQ:ABVX) Stock, Analyst Ratings, Price Targets, Forecasts

Abivax SA has a consensus price target of $35.63 based on the ratings of 8 analysts. The high is $50 issued by Guggenheim on April 29, 2024. The low is $16 issued by Morgan Stanley on April 11, 2024. The 3 most-recent analyst ratings were released by JMP Securities, JMP Securities, and Laidlaw & Co. on January 10, 2025, December 4, 2024, and July 29, 2024, respectively. With an average price target of $38 between JMP Securities, JMP Securities, and Laidlaw & Co., there's an implied 490.98% upside for Abivax SA from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Jul 24
0
0
0
0
Dec 24
0
0
0
0
Jan
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.9
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

JMP Securities
JMP Securities
Laidlaw & Co.
BTIG
Guggenheim

1calculated from analyst ratings

Analyst Ratings for Abivax

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Abivax (ABVX) stock?

A

The latest price target for Abivax (NASDAQ:ABVX) was reported by JMP Securities on January 10, 2025. The analyst firm set a price target for $33.00 expecting ABVX to rise to within 12 months (a possible 413.22% upside). 7 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Abivax (ABVX)?

A

The latest analyst rating for Abivax (NASDAQ:ABVX) was provided by JMP Securities, and Abivax reiterated their market outperform rating.

Q

When was the last upgrade for Abivax (ABVX)?

A

There is no last upgrade for Abivax

Q

When was the last downgrade for Abivax (ABVX)?

A

There is no last downgrade for Abivax.

Q

When is the next analyst rating going to be posted or updated for Abivax (ABVX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Abivax, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Abivax was filed on January 10, 2025 so you should expect the next rating to be made available sometime around January 10, 2026.

Q

Is the Analyst Rating Abivax (ABVX) correct?

A

While ratings are subjective and will change, the latest Abivax (ABVX) rating was a reiterated with a price target of $33.00 to $33.00. The current price Abivax (ABVX) is trading at is $6.43, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch